investor.opko.com investor.opko.com

investor.opko.com

Investor Relations | OPKO Health, Inc.

The Investor Relations website contains information about OPKO Health, Inc.'s business for stockholders, potential investors, and financial analysts.

http://investor.opko.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.OPKO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 17 reviews
5 star
7
4 star
6
3 star
2
2 star
0
1 star
2

Hey there! Start your review of investor.opko.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.7 seconds

CONTACTS AT INVESTOR.OPKO.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Relations | OPKO Health, Inc. | investor.opko.com Reviews
<META>
DESCRIPTION
The Investor Relations website contains information about OPKO Health, Inc.'s business for stockholders, potential investors, and financial analysts.
<META>
KEYWORDS
1 careers
2 diagnostics
3 diagnostics overview
4 bioreference laboratories
5 4kscore test
6 point of care diagnostics platform
7 therapeutics
8 therapeutics overview
9 renal
10 biologics
CONTENT
Page content here
KEYWORDS ON
PAGE
careers,diagnostics,diagnostics overview,bioreference laboratories,4kscore test,point of care diagnostics platform,therapeutics,therapeutics overview,renal,biologics,opko curna,protein based vaccines,asthma and copd,parkinson’s disease,cinv,overview,open
SERVER
nginx
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Relations | OPKO Health, Inc. | investor.opko.com Reviews

https://investor.opko.com

The Investor Relations website contains information about OPKO Health, Inc.'s business for stockholders, potential investors, and financial analysts.

INTERNAL PAGES

investor.opko.com investor.opko.com
1

OPKO Health, Inc. - Conferences & Events

http://investor.opko.com/events.cfm

OPKO Mexico Privacy Policy / Aviso de Privacidad. Mar 22, 2017. OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder more ». Mar 14, 2017. OPKO Health's GeneDx to have Significant Presence at ACMG 2017 more ». Mar 14, 2017. OPKO Health to Participate in the Barclays Global Healthcare Conference more ». Mar 8, 2017. OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder more ». More news ». Mar 15, 2017.

2

Two Reports on hGH-CTP Pediatric Phase 2 Clinical Data Accepted for Oral Presentation at the 54th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE conference) (AMEX:OPK)

http://investor.opko.com/releasedetail.cfm?ReleaseID=926003

Laquo; Previous Release. Next Release ». August 5, 2015. Two Reports on hGH-CTP Pediatric Phase 2 Clinical Data Accepted for Oral Presentation at the 54th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE conference). OPKO Health, Inc. And " Pharmacokinetic (PK) and Pharmacodynamics (PD) Modeling of MOD 4023 (a long-acting human growth hormone (hGH) in Growth Hormone Deficient (GHD) Children. Has been selected for oral presentation at the upcoming 54th Annual Meeting of the. Steve...

3

OPKO Health, Inc. - Investor Relations

http://investor.opko.com/index.cfm

OPKO Mexico Privacy Policy / Aviso de Privacidad. Aug 26, 2016. Transition Therapeutics Shareholders Approve Acquisition by OPKO Health more ». Aug 23, 2016. OPKO Health Responds to Law Firm Notice of Investigation more ». Aug 8, 2016. OPKO Health Reports Improved Financial and Operating Results more ». Aug 3, 2016. OPKO to Announce Second Quarter Operating and Financial Results on August 8, 2016 more ». More news ». Quotes delayed at least 20 minutes. Information provided by eSignal. 2016 OPKO Health Inc.

4

OPKO Health, Inc. - SEC Filings

http://investor.opko.com/sec.cfm

OPKO Mexico Privacy Policy / Aviso de Privacidad. Aug 26, 2016. Transition Therapeutics Shareholders Approve Acquisition by OPKO Health more ». Aug 23, 2016. OPKO Health Responds to Law Firm Notice of Investigation more ». Aug 8, 2016. OPKO Health Reports Improved Financial and Operating Results more ». Aug 3, 2016. OPKO to Announce Second Quarter Operating and Financial Results on August 8, 2016 more ». More news ». Frost, phillip md et al. Aug 26, 2016. Frost, phillip md et al. Aug 25, 2016. Aug 8, 2016.

5

OPKO Health, Inc. - Stock Information

http://investor.opko.com/stockquote.cfm

OPKO Mexico Privacy Policy / Aviso de Privacidad. Opko Health (NASDAQ: OPK). 4:00 PM ET on Aug 26, 2016. Sign up for email alerts. Former shareholders of Bio-Reference Laboratories, Inc. that have questions related to the exchange of BRLI shares to OPK shares, please contact our exchange agent, American Stock Transfer and Trust Company, LLC, toll free at (877) 248-6417 or (718) 921-8317. 2016 OPKO Health Inc.

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

bioreference.com bioreference.com

License/Quality Control | BioReference Laboratories

http://www.bioreference.com/license-quality-control

In addition, we routinely augment proficiency tests on a voluntary basis, with a comprehensive “In-House” program of quality control and assurance. Our internal program:. Utilizes blind split samples;. Reviews all control data carried out the previous 24 hours on a daily basis;. Monitors short and long term shifts and trends of control data;. Statistically reviews patient means data for the most commonly used tests;. Visit Our Other Sites. 481 Edward H. Ross Drive. Elmwood Park, NJ 07407.

bioreference.com bioreference.com

BioReference Laboratories

http://www.bioreference.com/thelaboratory

Find the nearest Laboratory. THE LABORATORY is a network of patient service centers that serve the unique entities of BioReference Laboratories. It is designed from top to bottom with patient comfort in mind. From the newly remodeled waiting rooms to the courteous and professional phlebotomists, THE LABORATORY is dedicated to delivering a positive experience to each and every patient. Johart Romulus, Phlebotomy Director. Thomas Pasko, Phlebotomy Director. Visit Our Other Sites. Elmwood Park, NJ 07407.

bioreference.com bioreference.com

HIPAA Privacy Statement | BioReference Laboratories

http://www.bioreference.com/hipaa-statement

Confidentiality of Health Information. These regulations impact the privacy and security of Protected Health Information by all health providers, including Bio-Reference Laboratories ( BRLI ). These regulations change how BRLI handles electronic transactions and code sets, national identifiers, and notification to patients whose unsecured PHI has been breached. Visit Our Other Sites. 481 Edward H. Ross Drive. Elmwood Park, NJ 07407. Sign up to get latest updates.

bioreference.com bioreference.com

Patient Payment Center | BioReference Laboratories

https://www.bioreference.com/payment

Need to Update Your Insurance Information? You will be able to use your credit card to pay your bill for the test you received easily and securely. Subsequently, you will receive an email receipt as confirmation of your payment. You will need your invoice number from your bill and credit card to start. Once you have them, please provide the information requested in the form. Found on the upper right hand corner of your statement). Patient First Name *. Patient Last Name *. Patient Phone Number *.

bioreference.com bioreference.com

Test Directory | BioReference Laboratories

http://www.bioreference.com/test-directory

If you are located in California, please call Campbell Client Services at 1-800-762-9722 for Test Codes and Specimen Requirements. Visit Our Other Sites. 481 Edward H. Ross Drive. Elmwood Park, NJ 07407. Sign up to get latest updates.

bioreference.com bioreference.com

Connectivity Solutions | BioReference Laboratories

http://www.bioreference.com/connectivity-solutions

CareEvolve has been connecting physicians to laboratories since 1999. CareEvolve provides an Internet-based order entry and results reporting solution for laboratory, pathology and radiology outreach businesses. CareEvolve’s EMR and EHR connectivity solutions can deliver results to, and accept orders from, virtually every electronic medical record system in the market today. More than 30,000 physicians use CareEvolve daily for Computerized Physician Order Entry (CPOE) and clinical results review.

bioreference.com bioreference.com

Specialized Departments | BioReference Laboratories

http://www.bioreference.com/specialized-departments

BioReference Laboratories offers healthcare providers a single source for all laboratory testing needs in both the primary care and specialty health care segments. BioReference takes great pride in the exceptional people who stand behind our services. Our specialized departments and dedicated team of highly-trained support personnel give us a diverse vantage point to handle all inquiries and requests with the utmost care and expertise. Billing Billing and insurance services. Visit Our Other Sites.

bioreference.com bioreference.com

FAQs | BioReference Laboratories

http://www.bioreference.com/faqs

How can I learn more about the tests my doctor has ordered? You can find accurate information about lab testing on the following websites:. 8211; Lab Tests Online. Http:/ www.webmd.com. 8211; Web MD. Http:/ ghr.nlm.nih.gov. 8211; Genetics Home Reference. For more detailed information, please contact your healthcare provider. How do I prepare for my tests? Can I continue to take medications before a test? Can I order my own tests? How can I obtain my test results? We love to hear from you! Your insurance ...

bioreference.com bioreference.com

HIPAA Resources | BioReference Laboratories

http://www.bioreference.com/hipaa-resources

We at Bio-Reference Laboratories ( BRLI ) and our subsidiary, CareEvolve, take very seriously our responsibility to protect patient rights. We therefore put great emphasis on protecting the privacy and security of your patient data that we handle daily, as required by the Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology Act (HITECH) regulations. This is especially important in this age of increased automation of electronic health information.

UPGRADE TO PREMIUM TO VIEW 127 MORE

TOTAL LINKS TO THIS WEBSITE

136

OTHER SITES

investor.oeconomia.info investor.oeconomia.info

Oeconomia.info | Vstupte do světa ekonomie a podnikání...

Přejít k hlavnímu obsahu. Vstupte do světa ekonomie a podnikání. Nový ekonomický web od nás! Připravili jsme pro Vás nový ekonomický web. Tentokrát zaměřený na začínající investory na burze. Web Burzovní investor. Vám dá základní rady do vašich investičních začátků. Nezávisle a prakticky, věříme že budou informace obsažené na webu. Pro čtenáře opravdu užitečné a ukáží jim, že investování může být zábava. A také, že není nutné jej svěřovat do rukou "finančních poradců". 22 Duben 2015 - 9:36 Micajir. To vš...

investor.officedepot.com investor.officedepot.com

Office Depot | Max - Investor Relations -Investor Relations

Office Depot, Inc. 160; 0.11. Office Depot, Inc. Announces Second Quarter 2015 Results. Office Depot, Inc. Recognized for Outstanding Product Quality and Service by David Weekley Homes. Office Depot, Inc. Offers Customers New Window of Opportunity with Free in-Store Installation of Windows 10 July 31. Office Depot, Inc. Thanks Educators with 25 Percent Discount During Teacher Appreciation Days in Stores August 1-4 and August 29-September 1. Â More Press Releases. Â More SEC Filings. Office Depot Q3 2014 ...

investor.omeros.com investor.omeros.com

Omeros - Investor Relations Home

Q2 2015 Omeros Corporation Earnings Conference Call. 160;at 1:30 pm PT. Q2 2015 Omeros Corporation Earnings Conference Call. Monday, August 10, 2015 . 1:30 pm PT  . Click here for webcast. Â Click here to add this event to your calendar. Here you will find financial reports and shareholder information about Omeros Corporation, including recent news, current and historical share price, and electronic copies of our SEC filings. 160; 0.07. Data as of 08/07/15Â 4:00 pm ET. Minimum 20 minute delay. Phase 2 Tr...

investor.omgi.com investor.omgi.com

OM Group : Investor Relations : Corporate Overview

OM Group, Inc. is a technology-driven diversified industrial company serving attractive global markets, including automotive systems, electronic devices, aerospace, industrial and renewable energy. We use innovative technologies to address customers' complex applications and demanding requirements. OM Groupâ s business platforms are strategically aligned with favorable long-term secular growth trends in its key markets and applications around the world. 160; 0.01. Data as of 08/07/15Â 4:02 pm ET. There a...

investor.omniarch.com investor.omniarch.com

President's Message | OmniArch

Skip to main content. Industry Support and Growth. Learn more about Exempt Market. What is an Alternative Investment? Dealer and Advisor Support. Dealer and Advisor Support. Industry Support and Growth. Learn more about Exempt Market. What is an Alternative Investment? There is rationale behind why the investment works, and why we are bringing it to our clients. Welcome to the OmniArch Investor Relations Website. When you think OmniArch, think of growth, comfort and security, think of the due diligence p...

investor.opko.com investor.opko.com

Investor Relations | OPKO Health, Inc.

Skip to main navigation. OPKO Mexico Privacy Policy / Aviso de Privacidad. Mar 23, 2018. OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes MORE. Mar 16, 2018. OPKO Health Announces Landmark Study Showing 4Kscore Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology MORE. Mar 01, 2018. OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results MORE. Feb 26, 2018. Sign up for email alerts. 2018 OPKO Health Inc.

investor.oplink.com investor.oplink.com

Oplink Communications, Inc. - Investors

Annual Reports and Proxy. Oct 30, 2014 at 2:00 PM PT. Oplink Communications (Nasdaq: OPLK) First Quarter Fiscal Year 2015 Financial Results Conference Call. Nov 19, 2014. Oplink to be Acquired by Koch Industries for $24.25 Per Share in Cash. Oct 30, 2014. Oplink Reports First Quarter of Fiscal Year 2015 Financial Results. Oct 23, 2014. Oplink to Report First Quarter Fiscal Year 2015 Results on October 30, 2014. View all releases ». 4:00 PM ET on Dec 22, 2014. View detailed stock quote ».

investor.opusbank.com investor.opusbank.com

Investor Relations - Opus Bank

Back to the Corporate Site. Sign on to your account. Credit Card Account Access. History of Opus Bank. Opus in the News. Annual Reports and Proxies. Market Cap: $960 Million. Russell 2000 Index Member. S&P Regional Banks Select Industry Index Member. Total Assets of $7.7 Billion. Want a deep dive into Opus Bank? Our custom research reports offer a thorough overview of how we do what we do. West Coast Multifamily Lending Report. Opus Bank's 3rd Quarter 2016 Earnings Conference Call. Monday, Oct 24, 2016.

investor.oracle.com investor.oracle.com

Oracle - Overview - Highlights

I want to . Oracle offers an optimized and fully integrated stack of business hardware and software systems. NYSE: ORCL Stock Quote. 36; 39.41. August 14, 2015 04:01 PM. Pricing delayed 20 minutes. 36; 39.18. 36; 39.31. Fourth Quarter Fiscal Year 2015 Press Release. Fourth Quarter Fiscal Year 2015 Press Release (PDF 106 KB. Detailed Financials (PDF 70 KB. Detailed Financials (XLSX 1.22 MB. Q1 FY2016 Guidance GAAP to non-GAAP EPS Reconciliation (PDF 229 KB. Calculations of Cloud Billing Growth (PDF 66 KB.

investor.org investor.org

Investor – For the individual self-guided investor

Investing – What Do You Really Know When You Think You Know? What do you really know when you think you know what stock to buy and when to buy it? Really. How deep do you go into understanding the fundamentals and predictable future trends – based upon currently available data – when it comes to picking a stock? Are you even clearly aware of the assumptions […]. When to Buy Stocks That Pay Dividends. Buying and Selling Cyclical Stocks. No The question is “do […]. Read the full article →.

investor.org.tw investor.org.tw

中華電信企業網路架站hiHosting-虛擬主機 網站代管 網頁空間 主機代管 網頁設計 電子商務 網域註冊 網路開店 郵件代管 網址申請 WebHosting